Test Price
650 AED✅ Home Collection Available
Dengue Virus PCR Qualitative Test in UAE | 650 AED
Executive Summary & Core Metrics
Dengue Virus PCR Qualitative Test – a molecular nucleic acid amplification test (NAAT) that qualitatively detects dengue virus RNA (serotypes 1–4) in whole blood, plasma, serum, or cerebrospinal fluid using Real-Time PCR (qPCR) with Whole Genome Sequencing (WGS) confirmation. This assay delivers 99.9% diagnostic sensitivity through ISO 9001:2015-accredited processing (Cert: INT/EGQ/2509DA/3139) and is the definitive molecular standard for confirming acute dengue viremia within the first 7 days of febrile illness. All clinical testing and patient data handling comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Molecular Processing
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM) for blood specimens; Cerebrospinal Fluid (CSF) collection requires hospital extraction
- Clinical Guidance: Telephonic Post-Test Clinical Correlation & Result Interpretation Consultation
- Pricing: 650 AED – Direct billing verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The Dengue Virus PCR Qualitative Test is a nucleic acid amplification test (NAAT) designed to detect the presence of Dengue virus serotypes 1–4 (DENV-1 to DENV-4) in patients presenting with acute febrile illness. Unlike serological NS1 antigen or IgM/IgG antibody tests, molecular PCR directly identifies viral RNA during the viremic phase (Days 1–7 post-symptom onset), offering the earliest and most specific confirmation of active dengue infection. This test is clinically indicated for suspected dengue cases, differential diagnosis of imported febrile illness in returning travelers, and pre-travel screening where molecular confirmation is required. The method combines Real-Time PCR (qPCR) amplification with Whole Genome Sequencing (WGS) confirmatory analysis for definitive serotype identification.
| Feature | Our Test — Dengue PCR + WGS | Closest Alternative — NS1 Antigen / IgM-IgG Serology |
|---|---|---|
| Methodology | Real-Time PCR (qPCR) + Whole Genome Sequencing (WGS) | ELISA-based NS1 Antigen Detection or IgM/IgG Immunochromatography |
| Diagnostic Window | Days 1–7 (Viremic Phase) — Earliest Detection Possible | NS1: Days 1–7 | IgM: Day 5+ | IgG: Day 7+ (Delayed Seroconversion) |
| Sensitivity | 99.9% (Molecular-Grade Precision) | ~85–92% (Variable; Cross-Reactive with Flaviviruses) |
| Specificity | >99.5% (Serotype-Specific via WGS Confirmation) | ~90–95% (Zika/Chikungunya Cross-Reactivity Risk) |
| Turnaround Time | Next Day (Sample by 11 AM) | 2–5 Working Days |
| Sample Types | Whole Blood (EDTA), Plasma, Serum, CSF | Serum Only |
| Regulatory Status | ISO 9001:2015 | DHA-Compliant | UAE PDPL | Variable Laboratory Accreditation |
Physician Insight & Safety Protocols
Clinical Note from Dr. Ajay Singh, DHA Registration ID 36234132 — General Practitioner:
"In my clinical practice across Dubai, I have found that the Dengue Virus PCR Qualitative Test is an indispensable tool for the early and accurate diagnosis of acute dengue infection. A positive molecular result confirms active viremia and enables timely clinical intervention—serial platelet monitoring, hematocrit surveillance, and hemodynamic assessment—which can significantly reduce the risk of progression to severe dengue or dengue shock syndrome. I advise all patients to discuss their results with their treating physician for a complete clinical interpretation. This test is a critical diagnostic aid but does not replace comprehensive medical evaluation."
Clinical Advisory
Medication Advisory
Do not discontinue or alter any prescribed medication—including antihypertensives, anticoagulants, antidiabetic agents, or immunosuppressants—without prior consultation with your treating physician. All test results must be interpreted within the full clinical context by a licensed healthcare professional. If you experience worsening symptoms, seek immediate medical attention.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria for Home Collection Service
- Patients with documented major bleeding disorders or severe thrombocytopenia requiring specialized venipuncture precautions (prior clinical arrangement required)
- Patients currently admitted to intensive care units (ICU) or emergency departments — phlebotomy must be performed by the treating facility
- Home collection for minors (<18 years) requires parental or legal guardian consent in compliance with UAE Federal Law
Emergency Red Flags — Seek Immediate Emergency Medical Attention If Present
- Severe, persistent abdominal pain or intractable vomiting
- Mucosal bleeding: gingival bleeding, epistaxis, melena, or hematemesis
- Lethargy, restlessness, confusion, or altered mental status
- Clinical signs of plasma leakage: pleural effusion, ascites, or pericardial effusion
- Rapidly declining platelet count (<100,000/µL) with concomitantly rising hematocrit (>20% above baseline)
- Circulatory collapse: narrow pulse pressure (<20 mmHg), cold extremities, or delayed capillary refill
If any of the above signs or symptoms are present, proceed immediately to the nearest emergency department. This PCR test is a diagnostic aid and does not replace emergency clinical evaluation.
Patient FAQ & Clinical Guidance
1. What is the Dengue Virus PCR Qualitative Test and when should I get tested?
The Dengue Virus PCR Qualitative Test detects dengue viral RNA in blood, plasma, serum, or cerebrospinal fluid with 99.9% diagnostic sensitivity within the first 7 days of symptom onset. This test is clinically indicated when you experience acute high-grade fever (≥38.5°C), severe retro-orbital headache, myalgia, arthralgia, or maculopapular rash following potential exposure in dengue-endemic regions, including recent travel history or known local transmission zones within the UAE. Early molecular testing is critical because the viremic window narrows after Day 7, at which point serological testing (IgM/IgG) becomes the preferred diagnostic modality.
2. How is the sample collected and what is the turnaround time for results?
A certified phlebotomist collects 3 mL of whole blood in an EDTA lavender-top tube through our VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection service, available daily from 8 AM to 11 PM. For patients requiring CSF analysis, sample collection must be performed in an accredited hospital setting by a qualified physician via lumbar puncture into a sterile screw-capped container. All specimens are transported under refrigerated cold-chain conditions (2–8°C) and must never be frozen, as freeze-thaw cycles degrade viral RNA and compromise diagnostic accuracy. Samples received by 11 AM are processed the same day, with results reported the next day via secure electronic delivery and optional telephonic consultation with our clinical team.
3. Do I need to fast or follow any special preparation before this test?
No special preparation, fasting, dietary modification, or medication discontinuation is required prior to sample collection for the Dengue Virus PCR Qualitative Test in the UAE. Patients may continue their regular diet, hydration, and all prescribed medications without interruption. However, we recommend adequate hydration before venipuncture to facilitate easier venous access. If you are taking anticoagulant therapy (e.g., warfarin, rivaroxaban, apixaban) or antiplatelet agents (e.g., aspirin, clopidogrel), please inform the phlebotomist at the time of collection so that extended compression protocols can be applied post-venipuncture to minimize bruising at the puncture site.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Accreditation
- ISO 9001:2015 Certified — Certificate No. INT/EGQ/2509DA/3139 (Quality Management Systems)
- DHA Facility License: 1143 — Dubai Health Authority Licensed & Regulated
- Federal Decree-Law No. 45 of 2021 (PDPL): Patient personal data and health information processed exclusively within UAE-sovereign infrastructure, with strict confidentiality and data minimization protocols
- Federal Law No. 2 of 2019: Full compliance with UAE healthcare data protection, electronic health records security, and information communication technology standards in health fields
- Federal Decree-Law No. 4 of 2016: Adherence to medical liability frameworks ensuring patient safety, informed consent, and clinical accountability
- Methodology: Real-Time PCR (qPCR) with LC-MS/MS-grade reagent validation and Whole Genome Sequencing (WGS) confirmatory analysis for serotype identification
- LOINC Code: 75362-9 — Dengue virus RNA [Presence] in Blood by NAA with probe detection
Clinical & Logistical Metadata
| Test Name | Dengue Virus PCR Qualitative Test |
| Price (AED) | 650 |
| Turnaround Time | Next Day (samples received by 11 AM) |
| Sample Type / Matrix | Whole Blood (EDTA), Plasma, Serum (VIP Mobile Phlebotomy Home Collection available); Cerebrospinal Fluid (Hospital Extraction Only) |
| Methodology Used | Real-Time PCR (qPCR) with Whole Genome Sequencing (WGS) Confirmation |
| ICD-10-CM Code | A90 (Dengue fever [classical dengue]) |
| LOINC Code | 75362-9 |
| DHA Facility License & Laboratory Address | DHA License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians